Anna Maria ZANELLATO,Vincenza CORSA,Giancarlo CARPANESE,Monica CAMPISI
申请号：
US15489299
公开号：
US20170216344A1
申请日:
2017.04.17
申请国别(地区):
US
年份:
2017
代理人:
摘要：
The present invention relates to pharmaceutical formulations containing a combination of specific high-molecular weight hyaluronic acid derivatives and chondroitin sulfate to be used in the treatment of osteoarthritis, of subchondral damage, osteoporosis, synovitis, tenosynovitis, tendinitis, tendinosis, as an intra-articular washing liquid and as a viscous substitute of synovial fluid following osteochondral surgery. These formulations are also suitable for the treatment of interstitial cystitis.
